Ellison Mark Jason Heath 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jun 29, 2022
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2022-06-27+2,000→ 21,636 total
Footnotes (1)
- [F1]Represents the acquisition of shares upon the determination on June 27, 2020 by the Compensation and Human Capital Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to a portion of the performance stock units granted to the Reporting Person on January 4, 2022.